This may include evidence relating to type 2 diabetes prevention, cardiovascular health and reductions in healthcare costs associated with obesity-related illnesses
GLP-1 Pipeline Update: February 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
Patients and doctors often overlook bone health and therefore leave bone loss untreated, she said
The obtained results will be crucial in designing a surrogate molecule for amphetamine that can help either in improving the efficacy and bioavailability of the amphetamine drug via competitive inhibition or in redesigning the drug for better pharmacological effects
BPC 157 may be beneficial for those dealing with gut health conditions like leaky gut syndrome, ulcerative colitis, or irritable bowel syndrome
All formulations remain HSA and FSA eligible, and no prior authorization or insurance approval delays access to therapy